首页|肾癌相关miRNAs及靶基因对肾癌预后的评估价值

肾癌相关miRNAs及靶基因对肾癌预后的评估价值

扫码查看
目的 基于美国癌症基因组图谱(TCGA)构建肾癌miRNAs预后风险模型评分公式,分析这个评分公式评估miRNAs及其靶基因作为肾癌预后分子标志物的潜在临床价值。方法 基于 TCGA 肾癌 miRNAs 与mRNA测序数据,采用单因素、Lasso和多因素Cox回归分析,构建肾癌miRNAs预后风险模型;通过对靶基因进行GO、KEGG富集分析,筛选相关miRNAs;在临床样本中验证预后风险模型中筛选出的miRNAs及其靶基因的表达。结果 基于TCGA数据库,在肾癌与其癌旁样本转录组数据中共找到 94 个差异miRNAs和 1 226个差异mRNAs,独立预后分析筛选得到7 个miRNAs。GO与KEGG富集分析结果提示,7 个miRNAs的功能与PI3K-Akt信号通路、钙离子信号通路、MAPK信号通路有关。采集肾癌临床样本,应用qPCR分析,结果显示,5 个miRNAs在肾癌临床样本中的表达模式与TCGA数据库中的表达模式一致,miRNAs的 8 个靶基因表达模式与其在TCGA数据库中的表达趋势一致。免疫组化结果显示,HPGD在肾癌中低表达。结论 构建的肾癌miRNAs预后模型能有效筛选肾癌预后相关miRNAs,这些miRNAs的研究对揭示肾癌发生与发展机制及评估肾癌预后具有重要意义。
Prognostic value of miRNAs and their target genes in renal cell carcinoma
Objective Based on the cancer genome atlas(TCGA),the miRNAs prognostic risk scoring model of renal cancer was constructed to evaluate the potential clinical value of miRNAs and its target genes as molecular markers for renal cancer prognosis.Methods Based on TCGA miRNAs and mRNA datasets,the prognostic risk scoring model of renal cancer miRNAs was constructed and verified by single-factor,Lasso and multi-factor Cox regression analysis.GO and KEGG enrichment analyses of target genes were performed to predict the related functions of miRNAs in prognostic risk scoring model of renal cancer.The expressions of miRNAs and their target genes in the prognostic risk scoring model of renal cancer were verified in clinical samples.Results Based on the TCGA database,94 differential expression miRNAs and 1 226 mRNAs were identified in the transcriptome data of renal cancer samples compared with pericarcinomatous tissue.7 miRNAs were screened by independent prognostic analysis and a prognostic risk scoring model of renal cancer was constructed.GO and KEGG enrichment analyses showed that the functions of the 7 miRNAs were related to the PI3K-Akt signaling pathway,calcium ion signaling pathway and MAPK signaling pathway.The results of qPCR verification in renal cancer tissues samples showed that the expression patterns of 5 miRNAs and 8 target genes of miRNAs in clinical samples were consistent with the trend in TCGA database.Imunohistochemistry results showed that HPGD was low expressed in renal cancer.Conclusion The miRNAs prognostic model constructed in this study can effectively screen for miRNAs related to the prognosis of renal cancer.The study of these miRNAs is of great significance for the mechanism of renal cell carcinoma occurrence and development,as well as the prognosis of renal cell cancer.

renal cancermiRNAstarget geneprognostic risk scoring model

聂倩茹、赵海东、杨小丽

展开 >

桂林医学院 公共卫生学院,桂林 541199

桂林医学院 科学实验中心,桂林 541199

肾癌 miRNAs 靶基因 预后风险模型

广西科技基地和人才专项

桂科AD23026329

2024

华夏医学
桂林医学院

华夏医学

影响因子:0.569
ISSN:1008-2409
年,卷(期):2024.37(2)
  • 25